Maryland lawmakers have introduced House Bill 1495, a significant piece of legislation aimed at enhancing healthcare access for women over the age of 45. The bill, introduced on February 12, 2025, mandates that health maintenance organizations (HMOs) in the state provide coverage for preventive screenings for ovarian cancer, including advanced imaging techniques like magnetic resonance imaging (MRI) and computed tomography (CT) scans.

One of the key provisions of House Bill 1495 is the elimination of copayments, coinsurance, or deductibles for these preventive screenings, ensuring that financial barriers do not prevent women from receiving essential health services. However, the bill does include a stipulation for individuals enrolled in high-deductible health plans, who may still be subject to their plan's deductible requirements.

The legislation is set to take effect on January 1, 2026, applying to all health policies and contracts issued or renewed in Maryland after that date. This timeline allows for health organizations to adjust their policies accordingly.

Supporters of the bill argue that it addresses a critical health issue, as ovarian cancer often goes undetected until it reaches advanced stages, making early detection vital for improving survival rates. By providing easier access to screenings, the bill aims to save lives and reduce the long-term healthcare costs associated with late-stage cancer treatment.

Opposition to the bill has been minimal, but some critics express concerns about the potential financial impact on health insurance providers, particularly those offering high-deductible plans. They argue that the requirement could lead to increased premiums for all policyholders.

As the bill moves through the legislative process, its implications for women's health in Maryland are clear. If passed, House Bill 1495 could significantly improve access to life-saving screenings, fostering a proactive approach to women's health and potentially reducing the incidence of late-stage ovarian cancer diagnoses in the state. The outcome of this legislation will be closely watched by health advocates and community members alike, as it represents a step forward in addressing women's health issues in Maryland.